David Kim, PharmD Candidate

David Kim is a Doctor of Pharmacy Candidate ('18) at MCPHS University in Boston, MA. He is currently serving his country as a pharmacy specialist in the United States Army Reserve and his community through working at a local hospital as a pharmacy intern. He is a certified immunizer and holds other APhA certifications in Medication Therapy Management and Diabetes Care. The views expressed in his publications do not reflect the views of the United States Army, Department of Defense, or the United States Government.
Pharmacists often encounter patients with Heparin-induced Thrombocytopenia (HIT) in health care settings. Here are some useful information in regards to HIT.
Apr 13, 2018 @07:56 PM
Tissue Plasminogen Activator (tPA) is administered in patients with Acute Ischemic Stroke. Becuase tPA administration is time sensitive, caution is required.
Feb 16, 2018 @02:00 PM
HMG-CoA reductase inhibitors are a class of lipid-lowering medications. Here is a look at guidelines and studies for health care professionals.
Dec 21, 2017 @04:25 AM
What role does this medication play in diabetes therapy, and what are its clinical benefits, compared with competitors?
Nov 16, 2017 @02:29 AM
Plantsvszombies.info Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Personalize the information you receive by selecting targeted content and special offers.
read more